Related content

Table 1. Summary of extracted biomarker and genomics data

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 62-62

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy

By Enns Gregory M.   Cowan Tina M.  

Journal of Clinical Medicine, Vol. 6, Iss. 5, 2017-05 ,pp. : 50-50

MDPI

Access to resources Recommend Favorite

Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice

By Morovat Alireza   Weerasinghe Gayani   Nesbitt Victoria   Hofer Monika   Agnew Thomas   Quaghebeur Geralrine   Sergeant Kate   Fratter Carl   Guha Nishan   Mirzazadeh Mehdi   Poulton Joanna  

Journal of Clinical Medicine, Vol. 6, Iss. 8, 2017-08 ,pp. : 80-80

MDPI

Access to resources Recommend Favorite

Serum α-fetoprotein level as a biomarker for early recurrence after R0 resection in primary hepatocellular carcinoma

By  

Family Medicine and Community Health, Vol. 1, Iss. 2, 2013-01 ,pp. : 9-14

Compuscript

Access to resources Recommend Favorite

Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta‐analysis

By  

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 2, 2018-02 ,pp. : 639-645

John Wiley & Sons Inc

Access to resources Recommend Favorite